Up-regulation of 12(S)-lipoxygenase induces a migratory phenotype in colorectal cancer cells

Experimental Cell Research

Volumn 318, Issue 6, 2012, Pages 768-778

  Klampfl, T ^a   Bogner, E ^a   Bednar, W ^a   Mager, L ^a   Massudom, D ^a   Kalny, I ^a   Heinzle, C ^a   Berger, W ^a   Stattner S ^b   Karner, J ^b   Klimpfinger, M ^b   Furstenberger G ^c   Krieg, P ^c   Marian, B ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b Social Medical Centre South   (Austria)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

12(S) HETE; Cell migration; E cadherin; Integrin; Lipoxygenase; Malignant phenotype

Indexed keywords

BETA1 INTEGRIN; LIPOXYGENASE; UVOMORULIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL; CANCER GROWTH; CELL CULTURE; CELL INTERACTION; CELL MIGRATION; CELL STRAIN CACO 2; CELL SURFACE; CLINICAL ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VIVO STUDY; INFLAMMATION; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; UPREGULATION;

EID: 84857655259     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2011.12.017     Document Type: Article

References (41)

1. Silverman E.S., Drazen J.M. The biology of 5-lipoxygenase: function, structure, and regulatory mechanisms. Proc. Assoc. Am. Physicians 1999, 111:525-536.
2. Funk C.D., Chen X.S., Johnson E.N., Zhao L. Lipoxygenase genes and their targeted disruption. Prostaglandins Other Lipid Mediat. 2002, 68-69:303-312.
3. Kühn H., O'Donnell V.B. Inflammation and immune regulation by 12/15-lipoxygenases. Prog. Lipid Res. 2006, 45:334-356.
4. Kuhn H. Biologic relevance of lipoxygenase isoforms in atherogenesis. Expert Rev. Cardiovasc. Ther. 2005, 3:1099-1110.
5. Kuhn H., Walther M., Kuban R.J. Mammalian arachidonate 15-lipoxygenases structure, function, and biological implications. Prostaglandins Other Lipid Mediat. 2002, 68-69:263-290.
6. Aleem A.M., Jankun J., Dignam J.D., Walther M., Kühn H., Svergun D.I., Skrzypczak-Jankun E. Human platelet 12-lipoxygenase, new findings about its activity, membrane binding and low-resolution structure. J. Mol. Biol. 2008, 376:193-209.
7. Yoshimoto T., Takahashi Y. Arachidonate 12-lipoxygenases. Prostaglandins Other Lipid Mediat. 2002, 68-69:245-262.
8. Wong B.C., Wang W.P., Cho C.H., Fan X.M., Lin M.C., Kung H.F., Lam S.K. 12-Lipoxygenase inhibition induced apoptosis in human gastric cancer cells. Carcinogenesis 2001, 22:1349-1354.
9. Ding X.Z., Iversen P., Cluck M.W., Knezetic J.A., Adrian T.E. Lipoxygenase inhibitors abolish proliferation of human pancreatic cancer cells. Biochem. Biophys. Res. Commun. 1999, 261:218-223.
10. Timar J., Raso E., Dome B., Li L., Grignon D., Nie D., Honn K.V., Hagmann W. Expression, subcellular localization and putative function of platelet-type 12-lipoxygenase in human prostate cancer cell lines of different metastatic potential. Int. J. Cancer 2000, 87:37-43.
11. Timar J., Raso E., Honn K.V., Hagmann W. 12-Lipoxygenase expression in human melanoma cell lines. Adv. Exp. Med. Biol. 1999, 469617-469622.
12. Timar J., Raso E., Fazakas Z.S., Silletti S., Raz A., Honn K.V. Multiple use of a signal transduction pathway in tumor cell invasion. Anticancer Res. 1996, 16:3299-3306.
13. Gao X., Grignon D.J., Chbihi T., Zacharek A., Chen Y.Q., Sakr W., Porter A.T., Crissman J.D., Pontes J.E., Powell I.J., Honn K.V. Elevated 12-lipoxygenase mRNA expression correlates with advanced stage and poor differentiation of human prostate cancer. Urology 1995, 46:227-237.
14. Honn K.V., Tang D.G., Grossi I.M., Renaud C., Duniec Z.M., Johnson C.R., Diglio C.A. Enhanced endothelial cell retraction mediated by 12(S)-HETE: a proposed mechanism for the role of platelets in tumor cell metastasis. Exp. Cell Res. 1994, 210:1-9.
15. Kerjaschki D., Bago-Horvath Z., Rudas M., Sexl V., Schneckenleithner C., Wolbank S., Bartel G., Krieger S., Kalt R., Hantusch B., Keller T., Nagy-Bojarszky K., Huttary N., Raab I., Lackner K., Krautgasser K., Schachner H., Kaserer K., Rezar S., Madlener S., Vonach C., Davidovits A., Nosaka H., Hammerle M., Viola K., Dolznig H., Schreiber M., Nader A., Mikulits W., Gnant M., Hirakawa S., Detmar M., Alitalo K., Nijman S., Offner F., Maier T.J., Steinhilber D., Krupitza G. Lipoxygenase mediates invasion of intrametastatic lymphatic vessels and propagates lymph node metastasis of human mammary carcinoma xenografts in mouse. J. Clin. Invest. 2011, 121:2000-2012.
16. Furstenberger G., Krieg P., Muller-Decker K., Habenicht A.J. What are cyclooxygenases and lipoxygenases doing in the driver's seat of carcinogenesis?. Int. J. Cancer 2006, 119:2247-2254.
17. Deschner E.E., Ruperto J.F., Wong G.Y., Newmark H.L. The effect of dietary quercetin and rutin on AOM-induced acute colonic epithelial abnormalities in mice fed a high-fat diet. Nutr. Cancer 1993, 20:199-204.
18. Deschner E.E., Ruperto J., Wong G., Newmark H.L. Quercetin and rutin as inhibitors of azoxymethanol-induced colonic neoplasia. Carcinogenesis 1991, 12:1193-1196.
19. Furstenberger G., Muller-Decker K., Scholz K., Loschke M., Lehmann W.D., Marks F. Different expression of prostaglandin-H synthase isozymes and lipoxygenases during multistage carcinogenesis in mouse skin. Adv. Exp. Med. Biol. 1997, 419-424.
20. Dubois R.N. Review article: cyclooxygenase-a target for colon cancer prevention. Aliment. Pharmacol. Ther. 2000, 14(Suppl. 1):64-67.
21. Bortuzzo C., Hanif R., Kashfi K., Staiano-Coico L., Shiff S.J., Rigas B. The effect of leukotrienes B and selected HETEs on the proliferation of colon cancer cells. Biochim. Biophys. Acta 1996, 1300:240-246.
22. Cianchi F., Cortesini C., Magnelli L., Fanti E., Papucci L., Schiavone N., Messerini L., Vannacci A., Capaccioli S., Perna F., Lulli M., Fabbroni V., Perigli G., Bechi P., Masini E. Inhibition of 5-lipoxygenase by MK886 augments the antitumor activity of celecoxib in human colon cancer cells. Mol. Cancer Ther. 2006, 5:2716-2726.
23. Tan W., Wu J., Zhang X., Guo Y., Liu J., Sun T., Zhang B., Zhao D., Yang M., Yu D., Lin D. Associations of functional polymorphisms in cyclooxygenase-2 and platelet 12-lipoxygenase with risk of occurrence and advanced disease status of colorectal cancer. Carcinogenesis 2007, 28:1197-1201.
24. Bednar W., Holzmann K., Marian B. Assessing 12(S)-lipoxygenase inhibitory activity using colorectal cancer cells overexpressing the enzyme. Food Chem. Toxicol. 2007, 45:508-514.
25. Sonvilla G., Allerstorfer S., Heinzle C., Stattner S., Karner J., Klimpfinger M., Wrba F., Fischer H., Gauglhofer C., Spiegl-Kreinecker S., Grasl-Kraupp B., Holzmann K., Grusch M., Berger W., Marian B. Fibroblast growth factor receptor 3-IIIc mediates colorectal cancer growth and migration. Br. J. Cancer 2010, 102:1145-1156.
26. Tang D.G., Chen Y.Q., Honn K.V. Arachidonate lipoxygenases as essential regulators of cell survival and apoptosis. Proc. Natl. Acad. Sci. U. S. A. 1996, 93:5241-5246.
27. Brash A.R. Lipoxygenases: occurrence, functions, catalysis, and acquisition of substrate. J. Biol. Chem. 1999, 274:23679-23682.
28. Honn K.V., Timar J., Rozhin J., Bazaz R., Sameni M., Ziegler G., Sloane B.F. A lipoxygenase metabolite, 12-(S)-HETE, stimulates protein kinase C-mediated release of cathepsin B from malignant cells. Exp. Cell Res. 1994, 214:120-130.
29. Honn K.V., Tang D.G., Grossi I., Duniec Z.M., Timar J., Renaud C., Leithauser M., Blair I., Johnson C.R., Diglio C.A., Kimler V.A., Taylor J.D., Marnett L.J. Tumor cell-derived 12(S)-hydroxyeicosatetraenoic acid induces microvascular endothelial cell retraction. Cancer Res. 1994, 54:565-574.
30. Nie D., Tang K., Szekeres K., Li L., Honn K.V. Eicosanoid regulation of angiogenesis in human prostate carcinoma and its therapeutic implications. Ann. N. Y. Acad. Sci. 2000, 905:165-176.
31. Ding X.Z., Tong W.G., Adrian T.E. 12-lipoxygenase metabolite 12(S)-HETE stimulates human pancreatic cancer cell proliferation via protein tyrosine phosphorylation and ERK activation. Int. J. Cancer 2001, 94:630-636.
32. Nie D., Honn K.V. Eicosanoid regulation of angiogenesis in tumors. Semin. Thromb. Hemost. 2004, 30:119-125.
33. Nie D., Nemeth J., Qiao Y., Zacharek A., Li L., Hanna K., Tang K., Hillman G.G., Cher M.L., Grignon D.J., Honn K.V. Increased metastatic potential in human prostate carcinoma cells by overexpression of arachidonate 12-lipoxygenase. Clin. Exp. Metastasis 2003, 20:657-663.
34. Shureiqi I., Chen D., Day R.S., Zuo X., Hochman F.L., Ross W.A., Cole R.A., Moy O., Morris J.S., Xiao L., Newman R.A., Yang P., Lippman S.M. Profiling Lipoxygenase Metabolism in Specific Steps of Colorectal Tumorigenesis. Cancer Prev. Res. 2010, 3:829-838.
35. Pidgeon G.P., Tang K., Cai Y.L., Piasentin E., Honn K.V. Overexpression of platelet-type 12-lipoxygenase promotes tumor cell survival by enhancing alpha(v)beta(3) and alpha(v)beta(5) integrin expression. Cancer Res. 2003, 63:4258-4267.
36. Szekeres C.K., Trikha M., Honn K.V. 12(S)-HETE, pleiotropic functions, multiple signaling pathways. Adv. Exp. Med. Biol. 2002, 507:509-515.
37. Vonach C., Viola K., Giessrigl B., Huttary N., Raab I., Kalt R., Krieger S., Vo T.P., Madlener S., Bauer S., Marian B., Hammerle M., Kretschy N., Teichmann M., Hantusch B., Stary S., Unger C., Seelinger M., Eger A., Mader R., Jager W., Schmidt W., Grusch M., Dolznig H., Mikulits W., Krupitza G. NF-kappaB mediates the 12(S)-HETE-induced endothelial to mesenchymal transition of lymphendothelial cells during the intravasation of breast carcinoma cells. Br. J. Cancer 2011, 105:263-271.
38. Takada Y., Ye X., Simon S. The integrins. Genome Biol. 2007, 8:215.
39. Kren A., Baeriswyl V., Lehembre F., Wunderlin C., Strittmatter K., Antoniadis H., Fassler R., Cavallaro U., Christofori G. Increased tumor cell dissemination and cellular senescence in the absence of beta1-integrin function. EMBO J. 2007, 26:2832-2842.
40. Pignatelli M., Smith M.E., Bodmer W.F. Low expression of collagen receptors in moderate and poorly differentiated colorectal adenocarcinomas. Br. J. Cancer 1990, 61:636-638.
41. Cavallaro U., Christofori G. Cell adhesion and signalling by cadherins and Ig-CAMs in cancer. Nat. Rev. Cancer 2004, 4:118-132.